These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9790918)

  • 1. Functional knock-out of c-myb by an intracellular anti-c-Myb single-chain antibody.
    Kasono K; Piché A; Xiang J; Kim HG; Bilbao G; Johanning F; Nawrath M; Moelling K; Curiel DT
    Biochem Biophys Res Commun; 1998 Oct; 251(1):124-30. PubMed ID: 9790918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetracycline-induced expression of an anti-c-Myb single-chain antibody and its inhibitory effect on proliferation of the human leukemia cell line K562.
    Kasono K; Heike Y; Xiang J; Piché A; Kim HG; Kim M; Hagiwara M; Nawrath M; Moelling K; Curiel DT
    Cancer Gene Ther; 2000 Jan; 7(1):151-9. PubMed ID: 10678368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking Myb to the cell cycle: cyclin-dependent phosphorylation and regulation of A-Myb activity.
    Ziebold U; Klempnauer KH
    Oncogene; 1997 Aug; 15(9):1011-9. PubMed ID: 9285555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci.
    Alm-Kristiansen AH; Saether T; Matre V; Gilfillan S; Dahle O; Gabrielsen OS
    Oncogene; 2008 Aug; 27(34):4644-56. PubMed ID: 18408764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic expression of c-Myb in chronic human liver disease.
    Kitada T; Seki S; Nakatani K; Kawada N; Kuroki T; Monna T
    Hepatology; 1997 Dec; 26(6):1506-12. PubMed ID: 9397991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated expression of dominant negative c-myb induces apoptosis in head and neck cancer cells and inhibits tumor growth in animal model.
    Kim SY; Yang YS; Hong KH; Jang KY; Chung MJ; Lee DY; Lee JC; Yi HK; Nam SY; Hwang PH
    Oral Oncol; 2008 Apr; 44(4):383-92. PubMed ID: 17690006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter.
    Bartůnek P; Králová J; Blendinger G; Dvorák M; Zenke M
    Oncogene; 2003 Apr; 22(13):1927-35. PubMed ID: 12673198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chicken adenosine receptor 2B gene is regulated by v-myb.
    Worpenberg S; Burk O; Klempnauer KH
    Oncogene; 1997 Jul; 15(2):213-21. PubMed ID: 9244356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb.
    Ladendorff NE; Wu S; Lipsick JS
    Oncogene; 2001 Jan; 20(1):125-32. PubMed ID: 11244510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse developing mouse lineages exhibit high-level c-Myb expression in immature cells and loss of expression upon differentiation.
    Ess KC; Witte DP; Bascomb CP; Aronow BJ
    Oncogene; 1999 Jan; 18(4):1103-11. PubMed ID: 10023687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
    Bessa M; Saville MK; Watson RJ
    Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myb binding proteins: regulators and cohorts in transformation.
    Ness SA
    Oncogene; 1999 May; 18(19):3039-46. PubMed ID: 10378699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The conserved DNA binding domain mediates similar regulatory interactions for A-Myb, B-Myb, and c-Myb transcription factors.
    Rushton JJ; Ness SA
    Blood Cells Mol Dis; 2001; 27(2):459-63. PubMed ID: 11259168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300.
    Tomita A; Towatari M; Tsuzuki S; Hayakawa F; Kosugi H; Tamai K; Miyazaki T; Kinoshita T; Saito H
    Oncogene; 2000 Jan; 19(3):444-51. PubMed ID: 10656693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells.
    Kim MS; Kim SY; Arunachalam S; Hwang PH; Yi HK; Nam SY; Lee DY
    Biochem Biophys Res Commun; 2009 Jul; 385(1):38-43. PubMed ID: 19427836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.